Teligent Cash on Hand 2012-2021 | TLGT
Teligent cash on hand from 2012 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Teligent Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2020 | $6 |
| 2019 | $16 |
| 2018 | $13 |
| 2017 | $27 |
| 2016 | $66 |
| 2015 | $87 |
| 2014 | $159 |
| 2013 | $2 |
| 2012 | $3 |
| 2011 | $3 |
|
Teligent Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2021-06-30 | $23 |
| 2021-03-31 | $28 |
| 2020-12-31 | $6 |
| 2020-09-30 | $10 |
| 2020-06-30 | $6 |
| 2020-03-31 | $11 |
| 2019-12-31 | $16 |
| 2019-09-30 | $7 |
| 2019-06-30 | $4 |
| 2019-03-31 | $7 |
| 2018-12-31 | $13 |
| 2018-09-30 | $15 |
| 2018-06-30 | $14 |
| 2018-03-31 | $13 |
| 2017-12-31 | $27 |
| 2017-09-30 | $38 |
| 2017-06-30 | $50 |
| 2017-03-31 | $59 |
| 2016-12-31 | $66 |
| 2016-09-30 | $75 |
| 2016-06-30 | $81 |
| 2016-03-31 | $87 |
| 2015-12-31 | $87 |
| 2015-09-30 | $146 |
| 2015-06-30 | $150 |
| 2015-03-31 | $157 |
| 2014-12-31 | $159 |
| 2014-09-30 | $23 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $3 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $2 |
| 2011-12-31 | $3 |
| 2011-09-30 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |